Volume 21, Issue 6, 2020
Meet Our Associate Editorial Board Member
Pp: 401-402
Author(s): Jonathan P. Mochel
DOI: 10.2174/138920022106200825123401
2020 FDA Drug-drug Interaction Guidance: A Comparison Analysis and Action Plan by Pharmaceutical Industrial Scientists
Pp: 403-426
Author(s): Sirimas Sudsakorn, Praveen Bahadduri, Jennifer Fretland and Chuang Lu*
DOI: 10.2174/1389200221666200620210522
Review on the Clinical Pharmacology of Hydroxychloroquine Sulfate for the Treatment of COVID-19
Pp: 427-435
Author(s): Cheng Cui, Siqi Tu, Valerie Sia Jie En, Xiaobei Li, Xueting Yao, Haiyan Li* and Dongyang Liu*
DOI: 10.2174/1389200221666200610172929
Preclinical Evidence for the Pharmacological Actions of Glycyrrhizic Acid: A Comprehensive Review
Pp: 436-465
Author(s): Muneeb U. Rehman*, Adil Farooq, Rayeesa Ali, Sana Bashir, Nazirah Bashir, Samia Majeed, Syed Taifa, Sheikh Bilal Ahmad, Azher Arafah, Aga Syed Sameer*, Rehan Khan, Wajhul Qamar, Saiema Rasool and Anas Ahmad
DOI: 10.2174/1389200221666200620204914
Strong Association between Serotonin Transporter 5-HTTVNTR Variant and Psychoactive Substance (Nicotine) Use in the Turkish Cypriot Population
Pp: 466-470
Author(s): Emine Kandemis, Gulten Tuncel, Ozen Asut, Sehime G. Temel and Mahmut C. Ergoren*
DOI: 10.2174/1389200221666200620201348
Effect of Green Tea and (-)-Epigallocatechin Gallate on the Pharmacokinetics of Rosuvastatin
Pp: 471-478
Author(s): Shenjia Huang, Qingqing Xu, Linsheng Liu, Yicong Bian, Shichao Zhang, Chenrong Huang* and Liyan Miao*
DOI: 10.2174/1389200221666200514133355